Role of in vitro metabolic interactions in the conduct of drug-drug interaction (DDI) studies.

被引：0
|
作者：
Yuan, R [1 ]
Balian, JD [1 ]
Svadjian, R [1 ]
Uppoor, RS [1 ]
Ajayi, F [1 ]
Burnett, A [1 ]
Lesko, LJ [1 ]
Marroum, P [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol & Biopharm, Rockville, MD 20857 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII46
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [21] Drug-drug interaction (DDI) of darolutamide with cytochrome P450 (CYP) and P-glycoprotein (P-gp) substrates: Results from clinical and in vitro studies.
    Zurth, Christian
    Graudenz, Kristina
    Denner, Karsten
    Korjamo, Timo
    Fricke, Robert
    Wilkinson, Gary
    Seitz, Friedeborg
    Prien, Olaf
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [22] CTF-DDI: Constrained tensor factorization for drug-drug interactions prediction
    Han, Guosheng
    Peng, Lingzhi
    Ding, Aocheng
    Zhang, Yan
    Lin, Xuan
    FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE, 2024, 161 : 26 - 34
  • [23] Design of in vitro studies to predict in vivo inhibitory drug-drug interactions
    Benedetti, MS
    Bani, M
    PHARMACOLOGICAL RESEARCH, 1998, 38 (02) : 81 - 88
  • [24] The impact of metabolic pathways to drug-drug interactions
    Wittmann, M.
    Koestlbacher, A.
    Hader, A.
    Koeber, R.
    Haen, E.
    PHARMACOPSYCHIATRY, 2011, 44 (06)
  • [25] Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver
    Ito, K
    Iwatsubo, T
    Kanamitsu, S
    Ueda, K
    Suzuki, H
    Sugiyama, Y
    PHARMACOLOGICAL REVIEWS, 1998, 50 (03) : 387 - 411
  • [26] Low risk of drug-drug interactions for Ruzasvir based upon in vitro metabolism and transporter interaction studies
    Vo, Alex
    Yabut, Jocelyn
    Hafey, Michael
    Wan, Hui
    Agrawal, Nancy
    Sommadossi, Jean-Pierre
    JOURNAL OF HEPATOLOGY, 2024, 80 : S753 - S753
  • [27] An Ensemble BERT CHEM DDI for Prediction of Side Effects in Drug-Drug Interactions
    Vijayan, Alpha
    Chandrasekar, B. S.
    INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING AND COMMUNICATIONS, ICICC 2022, VOL 3, 2023, 492 : 569 - 581
  • [28] DDI-Transform: A neural network for predicting drug-drug interaction events
    Su, Jiaming
    Qian, Ying
    QUANTITATIVE BIOLOGY, 2024, 12 (02) : 155 - 163
  • [29] A SYSTEMATIC REVIEW OF LIVER FUNCTION TEST ELEVATIONS IN RIFAMPIN DRUG-DRUG INTERACTION STUDIES.
    Ibrahim, S.
    Chen, J.
    Pithavala, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S63 - S63
  • [30] POINTS TO CONSIDER IN A DRUG-DRUG INTERACTION (DDI) STUDY WITH ORAL CONTRACEPTIVES (OC)
    Yu, C.
    Choi, S.
    Li, L.
    Dave, D.
    Kim, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S99 - S99
12345